Signature Therapeutics, Inc.
Signature Therapeutics is focused on creating novel medicines to improve upon the therapeutic utility of existing drugs.
Launch date
Employees
Market cap
-
Enterprise valuation
€36—55m (Dealroom.co estimates Dec 2011.)
San Carlos California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$10.0m | Series A | ||
N/A | Acquisition | ||
| Total Funding | €9.1m | ||
Recent News about Signature Therapeutics, Inc.
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.